Home Amplifier Therapeutics

Amplifier Therapeutics

In operation
Series A
Anti-aging Biologics Developer
Basic
Enterprise Profile

Basic Information

Amplifier Therapeutics is a biopharmaceutical company headquartered in Sweden, focusing on developing AMP-activated protein kinase (AMPK) activator compounds to treat aging-related diseases, including metabolic disorders, cardiovascular diseases, kidney diseases, and cancer. Additionally, these drugs have the potential to enable rapid consumption of excess lipids without exercise, achieving weight loss effects.
Amplifier TX AB
Sweden
15~50 people
January 01, 2001
rosa@cambrianbio.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Scientific Research and Experimental Development Services Biological Drug Production
Technology
Protein Technology
Concept
Cardiology Department Nephrology Department Tumor Cardiovascular Disease Metabolic Diseases Therapeutic Products Department of Nutrition
Application Scenarios
Innovative Drugs Biological Products